The research analyzes the progress of Member States in the implementation of Europe 2020 strategy targets and goals in 2016-2018. Multiple criteria decision-making approaches applied for this task. The set of headline indicators was divided into two logically explained groups. Interval entropy is proposed as an effective tool to make prioritization of headline indicators in separate groups. The sensitivity of the interval entropy is its advantage over classical entropy. Indicator weights were calculated by applying the WEBIRA (weight-balancing indicator ranks accordance) method. The WEBIRA method allows the best harmonization of ranking results according to different criteria groups-this is its advantage over other multiple-criteria methods. Final assessing and ranking of the 28 European Union countries (EU-28) was implemented through the α-cut approach. A k-means clustering procedure was applied to the EU-28 countries by summarizing the ranking results in 2016-2018. Investigation revealed the countries-leaders and countries-outsiders of the Europe 2020 strategy implementation process. It turned out that Sweden, Finland, Denmark, and Austria during the three-year period were the countries that exhibited the greatest progress according to two headline indicator groups' interrelation. Cluster analysis results are mainly consistent with the EU-28 countries' categorizations set by other authors.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000482 | PMC |
http://dx.doi.org/10.3390/e23030345 | DOI Listing |
Front Surg
January 2025
Department of Clinical Sciences, Umeå University, Umeå, Sweden.
Background: We analyzed trends in age at surgery and surgical approach over time and geography.
Methods: We performed a systematic review according to PRISMA-IPD guidelines to include individual patient data. Collected data included age at surgery, location of surgery, and surgical approach.
Front Med (Lausanne)
January 2025
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Introduction: The 2020 pharmaceutical strategy for Europe stressed that rethinking regulatory policies to foster innovation in disease areas with unmet medical needs (UMN) is one of the European Commission's (EC) priority areas. To understand stakeholders' views regarding appropriate UMN criteria and incentives, the EC developed a survey and launched it for public consultation between September and December 2021. This study aims to assess stakeholders' views on the policy revisions proposed by the EC, particularly those regarding the definition of UMN, its criteria and incentives and evaluate how stakeholders' views are reflected in the proposed reform of the EU pharmaceutical legislation of 2023.
View Article and Find Full Text PDFJ Health Monit
December 2024
Robert Koch Institute, Department of Epidemiology and Health Monitoring, Berlin, Germany.
Background: National health systems in Europe are facing similar challenges - demographic change, a rising burden of disease due to chronic non-communicable diseases, and health inequalities. Comparable health data and knowledge sharing between countries are therefore an important basis for policy decision-making. However, health information in the European Union (EU) is fragmented and approaches to establishing a comprehensive system are largely project-based.
View Article and Find Full Text PDFInfluenza Other Respir Viruses
January 2025
Nivel - Netherlands Institute for Health Services Research, Utrecht, The Netherlands.
Background: During the COVID-19 pandemic, atypical respiratory syncytial virus (RSV) circulation patterns emerged, with the occurrence of RSV activity outside the typical winter season. This study investigates the impact of COVID-19 and associated non-pharmaceutical interventions (NPIs) on RSV seasonality.
Methods: The onset, offset and peak of RSV epidemics from 2018 to 2022 across 12 European countries were determined using the 3% positivity threshold method.
BMC Med
January 2025
Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK.
Background: Polypharmacy (i.e., treatment with ≥ 5 drugs) is common in patients with atrial fibrillation (AF) and has been associated with suboptimal management and worse outcomes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!